Citation Impact
Citing Papers
The Tissue-Engineered Vascular Graft—Past, Present, and Future
2015 Standout
Platelet Reactivity in Male Smokers Following the Acute Consumption of a Flavanol-Rich Grapeseed Extract
2007
Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework
2017 Standout
Framing international trade and chronic disease
2011 Standout
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
Cocoa and Human Health: From Head to Foot—A Review
2013
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
Methods for evaluation of platelet function
2009 StandoutNobel
Flavan‐3‐ols: Nature, occurrence and biological activity
2007
Sepsis biomarkers: a review
2010 Standout
Traditional Chinese Medicine for Cardiovascular Disease
2017 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
2022 Standout
Current methods of assessing platelet function: relevance to transfusion medicine
2005
Effects of different blood components on clot retraction analysed by measuring elasticity with a free oscillating rheometer
2006 StandoutNobel
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
2013 Standout
Platelet reactivity and nonresponse to dual antiplatelet therapy: A review
2009
The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
2013 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials
2004 Standout
Definition, symptoms and risk of techno-stress: a systematic review
2018 Standout
Heterogeneity and changes in preferences for dying at home: a systematic review
2013 Standout
Chocolate, Lifestyle, and Health
2009
Antithrombotic Therapy for VTE Disease
2012 Standout
Platelet and Leukocyte Activation Correlate with the Severity of Septic Organ Dysfunction
2002
The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews
2003 Standout
Ticagrelor
2011
REVIEWLaboratory investigation of platelet function
1999
Highly Stereoselective Biocatalytic Synthesis of Key Cyclopropane Intermediate to Ticagrelor
2016 StandoutNobel
Recent advances in the transcriptional regulation of the flavonoid biosynthetic pathway
2011 Standout
Evaluation of platelet function, a method comparison
2005 StandoutNobel
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Endovascular Stroke Therapy Results Improve over Time: The ‘Learning Curve' at a New Comprehensive Stoke Center
2015 Standout
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel
2008
CD39 and CD73 in immunity and inflammation
2013 Standout
A strategy to reduce cardiovascular disease by more than 80%
2003 Standout
Small vessel disease: mechanisms and clinical implications
2019 Standout
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Ticagrelor: a P2Y12antagonist for use in acute coronary syndromes
2012
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
2007 Standout
The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation
2003 StandoutNobel
Ecto-5′-Nucleotidase: A Candidate Virulence Factor in Streptococcus sanguinis Experimental Endocarditis
2012
Measuring antiplatelet drug effects in the laboratory
2007
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial
2019
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
Platelet PAR1 receptor density—Correlation to platelet activation response and changes in exposure after platelet activation
2007 StandoutNobel
Can Treatment Adherence Be Improved by Using Rubin's Four Tendencies Framework to Understand a Patient's Response to Expectations
2017 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Optimal duration of exclusive breastfeeding
2012 Standout
Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination
2017
Cocoa and Heart Health: A Historical Review of the Science
2013
Guidelines for the Primary Prevention of Stroke
2014 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: A randomized, single-blind, 30-day trial
2008
A circadian gene expression atlas in mammals: Implications for biology and medicine
2014 Standout
Status, supply chain and processing of cocoa - A review
2017 Standout
The Role of Polyphenols in Abiotic Stress Response: The Influence of Molecular Structure
2021 Standout
Burden of Stroke in Europe
2020 Standout
A scoping review of scoping reviews: advancing the approach and enhancing the consistency
2014 Standout
Cardiovascular Effects of Flavonoids
2018
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Oral Glycoprotein IIb/IIIa Inhibition With Orbofiban in Patients With Unstable Coronary Syndromes (OPUS-TIMI 16) Trial
2000
The role of polyphenols in cardiovascular disease.
2010
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
2017
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Sue Fox being referenced
Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke
2005
Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood
1998
Quantitation of platelet aggregation and microaggregate formation in whole blood by flow cytometry
2004
Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1and P2Y12receptors: A new finding that may influence the design of anti-thrombotic agents
2008
Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin
2009
Cocoa Flavanols and Platelet and Leukocyte Function: Recent In Vitro and Ex Vivo Studies in Healthy Adults
2006
Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1
2003
Mode of action of P2Y12 antagonists as inhibitors of platelet function
2010
P2Y12and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP
2011
Adenosine Derived From ADP Can Contribute to Inhibition of Platelet Aggregation in the Presence of a P2Y 12 Antagonist
2010